STAFF

Christine Cole

Senior Director, Head of Philanthropy & Partnerships

Jennifer Francis

Executive Assistant

Erica Mawby-Roche

Senior Director of Programs

Dan Ouellette

Programs Manager

Ageena Peterson

Operations & Office Manager

Catharine Smith

Executive Director

Lorie Umanita

Administrative Coordinator

BOARD OF DIRECTORS

Deborah Dunsire, M.D.

Mentor and Member of the Board of Directors; Chairman of Neurvati Neurosciences, Board Member of MacKesson, Ultrage tc and Vima Therapeutics, Former CEO H. Lundbeck A/S, FORUM XTuit, Millennium, Advisor at Blackstone Lifesciences

Paul Hastings

Mentor and Member of the Board of Directors; President and CEO, Nkarta Therapeutics and Chair of the Board, Biotechnology Innovation Organization (BIO)

Gail Maderis

Member of the Board of Directors; President and CEO of Antiva Biosciences, member of the Board of Directors at Valitor Inc., the Biotechnology Innovation Organization (BIO), and the California Life Sciences Institute

John Maraganore

Mentor and Member of the Board of Directors; CEO and Director at Alnylam Pharmaceuticals, Chair of the Board for Agios Pharmaceuticals, co-chair of the Termeer Tribute Committee, and member of the Biotechnology Innovation Organization (BIO) Executive Committee.

Alice Pomponio

Member of the Board of Directors; Managing Director of BrightEdge and Vice President of Innovation and Impact Investing at the American Cancer Society, Board Observer at NAVERIS, and Board Observer at Vincere Health. 

Joan Reede, M.D.

Member of the Board of Directors; Dean for Diversity and Community Partnership at Harvard Medical School, President of the Biomedical Science Careers Program.

Belinda Termeer

President, Co-Founder and Member of the Board of Directors; Termeer Foundation; Head of the Termeer family office; member of the Board of Directors, PIC Therapeutics; Board of Fellows and the Discovery Council, Harvard Medical School; member, MIT Museum Advisory Board; member of the Board, BIO Ventures for Global Health; member of Presidents Council, Massachusetts General Hospital; Trustee Emeriti, the Boston Ballet; Board Observer, Aleta Biotherapeutics; Board Observer, Artax Biopharma; member of the Board of Directors, Chrysalis Genetics

Alan Walts

Treasurer, Secretary, Mentor, Co-Founder and Member of the Board of Directors; Venture Partner with Advent Life Sciences, Executive Chairman of PIC Therapeutics and Artax Biopharma, Board Member of Eloxx Pharmaceuticals and Neuroelectrics Corp, Board Observer at Amylyx Pharmaceuticals and Arrakis Therapeutics, Advisory Board Member of the ALS Investment Fund

Mentors

Jeff Albers

Executive Chairman of the Board of Directors, Blueprint Medicines

Oved Amitay

Experienced Biotech Executive and Patient Advocate

Jens Bitsch-Norhave

Vice President of Transaction & Innovation Partnering, Johnson & Johnson Innovation

Mike Bonney

Executive Chair, Kaleido

Katharine Bowdish

President & CEO, PIC Therapeutics

Sarah Boyce

President & CEO, Avidity Biosciences

John Butler

President & CEO, Akebia

Josh Cohen

Co-CEO & Co-Founder, Amylyx Pharmaceuticals

Rod Cotton

Healthcare, Biotech & Pharma Executive

Daniel de Boer

Founder & CEO, ProQR

Elisabet de los Pinos

Founder & CEO, Aura Biosciences

Deborah Dunsire, M.D.

Former President & CEO, H. Lundbeck A/S

Mark Enyedy

Former President & CEO, ImmunoGen

Kevin Finney

Chairman & CEO, Autobahn Therapeutics

Paul Fonteyne

Executive in Residence, Canaan Partners

Sarah Fredriksson

CEOAQILION AB

Jim Geraghty

Board Director & Chair, Healthcare Leader

Michael Gilman

CEO, Arrakis Therapeutics

Tom Graney

Experienced Biotech Executive

Molly Harper

Member Board of Directors, Catalyst Pharmaceuticals and Precise Dx

Paul Hastings

CEO, Nkarta Therapeutics

Kate Haviland

CEO, Blueprint Medicines

Marie-Louise Hovgaard Sveen

Head of US R&D Operations, Novo Nordisk

Colin Hill

Co-Founder & CEOAitia

Enoch Kariuki

President, Endeavor Biomedicines

Ed Kaye

CEO, Stoke Therapeutics

Justin Klee

Co-CEO & Co-Founder, Amylyx Pharmaceuticals

Art Krieg

Founder, President & CEOZola Therapeutics

Alison Lawton

Special Advisor to Office of CEO,
Kaleido Biosciences

Juan Carlos Lopez

Founder, Haystack Science

Gail Maderis

Chairman of the Board, Antiva Biosciences 

Hilary Malone

CEO, Stylus Medicine

John Maraganore

Former Founding CEO, Alnylam

Kristina Masson

Co-Founder and Executive Vice President of Business Operations, Acrivon Therapeutics Inc. President and CEO, Acrivon AB

Tom Mathers

Founder, President & CEO,
Allievex Corporation

Geoff McDonough

President & CEO, Generation Bio

David Meeker

Chairman, President & CEO,
Rhythm Therapeutics

Lydia Meyer-Turkson

Experienced Biotech Executive, Board Member, Research Bridge Partners

Ann Miller, M.D.

Member Board of Directors, Inovio Pharmaceuticals, Puma Biotechnology, and Allena Pharmaceuticals

Mike Minogue

Former Chairman, President & CEO, Abiomed

Richard Moscicki

Former Executive Vice President for Science and Regulatory Advocacy & Chief Medical Officer, Pharmaceutical Research and Manufacturers of America (PhRMA)

Masako Nakamura

President & COO, Chrysalis Genetics

Imran Nasrullah

VP & Head, Collaborate2Cure Hub, US, BD&LBayer

Doug Onsi

President & CEO, Leap Therapeutics

Paula Ragan

CEO, X4 Pharmaceuticals

Bart Scheerder

Business Developer, Data Driven Science & AI, UMCG Innovation Center

Hans Schikan

Top Team Member, Health Holland

Alicia Secor

President & CEO, Atalanta Therapeutics

Paul Sekhri

Chairman, President & CEO, vTv Therapeutics

Christy Shaffer

Partner, Hatterras Venture Partners 

Craig Shimasaki

Co-Founder & CEO, Moleculera Biosciences

Paula Soteropoulos

Chair of the Board, Ensoma

Rand Sutherland

CEOUpstream Bio

Dinko Valerio

Scientist-turned-Entrepreneur

Stephane van Rooijen

CEO, Flamingo Therapeutics

Willem van Weperen

CEO, Pluvia Biotech

Alan Walts

Treasurer, Secretary, Board of Directors,
The Termeer Foundation

Gene Williams

Chairman and Co-FounderProMIS™ Neurosciences, Inc.

Troy Wilson

President and CEOKura Oncology, Inc.

Peter Wirth

Venture Partner, Quan Capital Management

James Xue

Founder, Chairman & CEO,
CANbridge Pharmaceuticals

Andrey Zarur

 Founder & CEO, GreenLight Biosciences, Inc.

Advisors

Sun Altbach

Areas of Expertise: Seed and Equity Financing, Advancing Pipelines from Discovery to Research

Lindsay Androski

Area of Expertise: Licensing and Acquisitions

Greg Butz

Area of Expertise: Capital Raising, Partnering, Mergers, and Acquisitions

Bethany Cavanagh

Area of Expertise: Building Finance Teams, FP&A

Buket Grau

Area of Expertise: M&A, Partnering, Relationship Building with External Stakeholders

Missy Green

Area of Expertise: HR

Dan Haines

Areas of Expertise: Legal

Robert Hesslein

Areas of Expertise: Legal, Combinate, Mergers and Acquisitions

Theo Hill

Areas of Expertise: Medical Affairs, Go-To-Market Strategies, Structure, Governance, Rare Disease

Bjorn Koch

Areas of Expertise: Equity Compensation, Corporate Finance Solutions, Capital Formation Strategy

Danielle Lauzon

Areas of Expertise: Legal- VC & Growth Equity Financing, Public Offerings, M&A

Donna LaVoie

Areas of Expertise: Communications Strategy, Telling Your Story

Daniel Leonard

Area of Expertise: Patient Advocacy

Alyssa Levin

Areas of Expertise: Fundraising (Seed-IPO), Mergers, Finance, Licensing Out Tech

Mark Levin

Areas of Expertise: Company Creation, Company Building

Isaac Meek

Areas of Expertise: Commercialization, Licensing and Transactions

Trista Morrison

Areas of Expertise: Pitches and Presentation Skills

Fran Nolan

Areas of Expertise: Communications and Messaging

Bhavesh Patel

Areas of Expertise: Cyber Security, Security Products, Protecting Information

Kyle Peterson

Areas of Expertise: Finance and Accounting

Michelle Quinn Smith

Areas of Expertise: Culture, Employee Engagement, Compensation Structure

Chandra Ramanathan

Areas of Expertise: Journey from Concept to Product

Jamie Ring

Areas of Expertise: Patient Advocacy/Engagement, Crisis Communications

Katie Rubino

Areas of Expertise: Patents, IP Strategy, Term Sheets, Licensing

Susan Stewart

Areas of Expertise: Regulatory Strategy, Navigating the FDA

Dustin Tyner

Areas of Expertise: Capital Raising, Partnering, Mergers, and Acquisitions